Atlas Trials

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

Clinical trial NCT06334510 · COMPLETED

Trial details

NCT number
NCT06334510
Sponsor
Hualan Biological Bacterin Co. Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
GCP
Start date
2021-11-17
Primary completion
2023-01-20
Enrollment
4900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.